Softwr

Research · head to head

Medidata Rave vs Schrodinger

Medidata Rave logo

Medidata Rave

Research

Electronic data capture for regulated clinical trials, sold only through a sales process

From
On request
Rated
-
Full reviewWebsite
Schrodinger logo

Schrodinger

Research

Physics based molecular modelling and drug discovery software, licensed by token pool

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Medidata Rave no pricing is published at all, so a first time sponsor cannot budget a study without entering a sales process and usually cannot benchmark the quote against anything.; Schrodinger licences are sold as token pools rather than unlimited module access, so a department can be blocked mid campaign because colleagues are consuming concurrency, and expanding the pool is a new commercial negotiation rather than a setting.
  • They diverge on capability: Medidata Rave covers Case report form design, Schrodinger covers Maestro.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Medidata Rave and Schrodinger actually diverge.

Attributes where Medidata Rave and Schrodinger differ
AttributeMedidata RaveSchrodinger
PlatformsWebLinux, macOS, Windows, Web

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Medidata Rave

  • Case report form design
  • Edit checks and queries
  • Part 11 audit trail
  • Rave Lite
  • Coding and safety
  • Platform integrations

Only in Schrodinger

  • Maestro
  • Glide
  • FEP+
  • Desmond
  • Jaguar
  • LiveDesign
  • Materials Science suite

What people use each for

The jobs each tool is most often brought in to do.

Medidata Rave

  • A sponsor running a registrational Phase III study where inspection readiness and a validated audit trail are non negotiablenot Schrodinger
  • A biotech that wants its CRO to run data management and benefits from the CRO already having Rave trained staff and templatesnot Schrodinger
  • A sponsor standardising forms across a programme so that a global library is reused rather than each study being built from scratchnot Schrodinger
  • A device or Phase IV study where Rave Lite gives the same compliance posture at a lower configuration burdennot Schrodinger

Schrodinger

  • A medicinal chemistry programme using FEP+ to prioritise which analogues to synthesise, where avoiding a handful of wasted syntheses pays for the licencenot Medidata Rave
  • A structure based design campaign that needs docking at scale against a target with a good crystal structurenot Medidata Rave
  • A materials group modelling polymer or electrolyte properties before committing to formulation experimentsnot Medidata Rave
  • A university modelling group that qualifies for the published academic site licence and needs Maestro across a teaching and research cohortnot Medidata Rave

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Medidata Rave

  • No pricing is published at all, so a first time sponsor cannot budget a study without entering a sales process and usually cannot benchmark the quote against anything.
  • Cost is dominated by study build rather than licence, and every protocol amendment that changes a form triggers billable rework, so a study with unstable protocols costs far more than the initial quote implied.
  • Configuration requires trained specialists, so most sponsors cannot build a study in house and are dependent on Medidata professional services or a CRO, which lengthens startup.
  • The system assumes a professional clinical data management function; a small sponsor without data managers will not operate it directly and will pay a CRO to do so.
  • Deep use of the wider Medidata platform for randomisation, imaging and patient reported data creates commercial lock in, because moving EDC later means unpicking integrations that were bought as one bundle.

Schrodinger

  • Licences are sold as token pools rather than unlimited module access, so a department can be blocked mid campaign because colleagues are consuming concurrency, and expanding the pool is a new commercial negotiation rather than a setting.
  • Commercial pricing is not published and is negotiated against modules, cores and term, so two companies of similar size can pay very different amounts and neither can benchmark the other.
  • FEP+ needs substantial GPU capacity that is not included in the licence, so the real annual cost includes cloud or on premise hardware that often rivals the software line item.
  • The tools require trained computational chemists to produce trustworthy results, and an organisation without that function will generate predictions it cannot interpret or defend to its own medicinal chemists.
  • Schrodinger runs its own internal drug discovery pipeline alongside selling software to discovery companies, and some prospective customers treat that dual role as a conflict when discussing proprietary targets, which slows procurement even where contractual separation exists.

Pricing, plan by plan

Medidata Rave

On request
  • Medidata Rave EDC$undefined/year
    • Priced per study through a sales process
    • Study build and configuration charged separately from licence
    • Mid study amendments generally billable

Schrodinger

On request
  • Commercial licence$undefined/year
    • Quoted per customer against modules, cores and licence term
    • Applications draw from a shared token pool that caps concurrency
    • GPU compute for FEP+ and Desmond is a separate cost, on premise or cloud
  • Academic site licence$undefined/year
    • Published academic entry around 7,500 USD a year for a premium package with a token allocation
    • Restricted to academic and research use, not work supporting a commercial enterprise
    • Maestro generally unrestricted with tokens shared for compute heavy applications

Which should you pick?

Choose Medidata Rave if

  • You need case report form design.
  • You also want edit checks and queries.
Medidata Rave review

Choose Schrodinger if

  • You need maestro.
  • You work on Linux, macOS, Windows, Web.
  • You also want glide.
Schrodinger review

Questions people ask

Is Medidata Rave or Schrodinger better?
Neither clearly leads. Medidata Rave starts at On request and Schrodinger at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Medidata Rave or Schrodinger?
Medidata Rave starts at On request and Schrodinger at On request.
Does Medidata Rave or Schrodinger run on more platforms?
Medidata Rave runs on Web. Schrodinger runs on Linux, macOS, Windows, Web.
What is Medidata Rave best used for?
Medidata Rave is most often used for a sponsor running a registrational phase iii study where inspection readiness and a validated audit trail are non negotiable, a biotech that wants its cro to run data management and benefits from the cro already having rave trained staff and templates, a sponsor standardising forms across a programme so that a global library is reused rather than each study being built from scratch, a device or phase iv study where rave lite gives the same compliance posture at a lower configuration burden. Of those, a sponsor running a registrational phase iii study where inspection readiness and a validated audit trail are non negotiable and a biotech that wants its cro to run data management and benefits from the cro already having rave trained staff and templates are not what Schrodinger is typically brought in for.
What can Medidata Rave do that Schrodinger cannot?
Medidata Rave covers Case report form design, Edit checks and queries, Part 11 audit trail, Rave Lite. Schrodinger covers Maestro, Glide, FEP+, Desmond.

Answered from the vendors’ own pages

Medidata Rave: Who owns Medidata?

Dassault Systemes, which acquired Medidata in 2019. Rave is sold as part of the Dassault life sciences portfolio.

Schrodinger: How is Schrodinger software licensed?

Annual licences with a shared token pool. Tokens cap how much you can run at once rather than which modules you own outright.

Medidata Rave: How is Rave priced?

Per study, through a sales process. Nothing is published, and study build and amendments are charged separately from the licence.

Schrodinger: Is there published pricing?

Only for academic site licences, which start around 7,500 USD a year for a premium package. Commercial pricing is quoted.

Medidata Rave: Is Rave validated out of the box?

Medidata supplies validation and qualification documentation, but the sponsor still owns study level user acceptance testing and its own validation evidence.

Schrodinger: Do I need my own GPUs?

For FEP+ and Desmond in practice yes, or cloud GPU capacity. Compute is not included in the licence.

Medidata Rave: What is Rave Lite for?

Lower complexity studies, typically Phase I, Phase IV and medical device, where a full study build is not justified.

Schrodinger: Does Schrodinger compete with its customers?

It runs its own drug pipeline as well as selling software. It manages this through contractual separation, but buyers with sensitive targets should raise it during procurement.

Share

Related pages

More on Medidata Rave

More on Schrodinger

Keep looking

Other head to heads